PTEN and prostate carcinoma: Accordingly, Pten-deficient prostates develop castration-resistant prostate cancer (Mulholland et al., 2011; Wang et al., 2003) that are highly enriched in cancer stem cells (this report) (Goldstein et al., 2010; Mulholland et al., 2009; Wang et al., 2014a).